Pharma Reviews: OrbiMed Asia invests $7.5 mln more in Vivimed Labs unit

... business growth and, increase the Company's profitability by organic and inorganic Growth opportunities,” added Saurabh Gurnurkar, Executive Director of Uquifa. Vivimed is a Pharmaceuticals and Specialty Chemicals company headquartered in Hyderabad, India. It has manufacturing plants in India, ...
Read more: OrbiMed Asia invests $7.5 mln more in Vivimed Labs unit

Pharma Reviews: India and the future of life sciences innovation

The Indian pharmaceutical industry is a world leader in bringing generic drugs to the market in a cost-effective way. Additionally, many Western pharmaceutical companies have established small-molecule development and manufacturing in India. More recently, Indian pharma companies have ...
Read more: India and the future of life sciences innovation

US FDA News: FDA permits marketing of device to treat diabetic foot ulcers

FDA permits marketing of device to treat diabetic foot ulcers
Read more: FDA permits marketing of device to treat diabetic foot ulcers

Pharma Reviews: Bank of Baroda buys out Pioneer Investments from AMC unit

It will acquire 51% of Baroda Pioneer Asset Management Company for an undisclosed amount. This is being done due to the acquisition of Pioneer Investments by Amundi, which already has India operations. The company said it will explore the option of bringing in another partner. A year ago ...
Read more: Bank of Baroda buys out Pioneer Investments from AMC unit

Pharma Reviews: Pharma 2018: Expect more M&As, USFDA reinspections in a normalised year

What is the outlook for Indian pharma in 2018? Analysts tend to think that it's a bit uncertain but many still feel the worst may be over. The last three fiscal years have been challenging for Indian pharma companies. The year 2015/16 saw price regulations being rung in by the pricing regulator. The next ...
Read more: Pharma 2018: Expect more M&As, USFDA reinspections in a normalised year

Pharma Reviews: Complex generics, domestic demand to help pharma weather regulated market de-growth

The Indian pharmaceutical industry will weather the current headwinds of slowdown in exports caused by regulatory scrutiny and intensifying competition, by monetising opportunities in complex products in the regulated markets, and because of resilient domestic demand, according to credit rating ...
Read more: Complex generics, domestic demand to help pharma weather regulated market de-growth

Pharma Reviews: Pharma 2019: Expect more M&As, USFDA re-inspections, a normalized year despite domestic ...

What is the outlook for the Indian pharma companies in 2019? Analysts tend to think while the outlook is a bit murky in India but still many feel the worst may be over with FY16 seeing price regulations from the price regulator, FY 17 seeing demonetization and FY 18 the impact of switchover to Goods and ...
Read more: Pharma 2019: Expect more M&As, USFDA re-inspections, a normalized year despite domestic ...

Pharma Reviews: Growth will return to pharma sector in 2018: V Srivatsa of UTI Mutual Fund

But since last year, the Indian pharma has specifically being impacted by demonetisation and to some extent GST. Also, in the last three years, there have been additional pricing control and more importantly there was a ban on some stores also which impacted certain companies. Having said that, we ...
Read more: Growth will return to pharma sector in 2018: V Srivatsa of UTI Mutual Fund

Pharma Reviews: Pharmaceutical stocks regain health as brokers turn bullish

Pharmaceutical stocks seem to have regained their health, as the stocks notched up gains of up 15% on Wednesday. Indian pharmaceutical market's (IPM) secondary sales continued to grow at a healthy rate in November, led by strong volume growth, said Motilal Oswal in a report. “After declining 0.5% ...
Read more: Pharmaceutical stocks regain health as brokers turn bullish

Pharma Reviews: 'Biosimilars need huge investments, longer timelines'

Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, is elated about not only her company's achievements as the first Indian biotech company to get a US FDA nod for a biosimilar drug but is more happy about India and its talent making a mark in the global arena to prove naysayers ...
Read more: 'Biosimilars need huge investments, longer timelines'

Pharma Reviews: Complex generics to help pharma weather regulated market de-growth: Crisil

CRISIL believes the Indian pharmaceutical industry will weather the current headwinds of slowdown in exports caused by regulatory scrutiny and intensifying competition, by monetising opportunities in complex products in the regulated markets, and because of resilient domestic demand. The sector's ...
Read more: Complex generics to help pharma weather regulated market de-growth: Crisil

Pharma Reviews: Complex generics, domestic demand to help pharma weather regulated market de-growth: CRISIL

Complex generics, domestic demand to help pharma weather regulated market de-growth: CRISIL ... CRISIL believes the Indian pharmaceutical industry will whether the current headwinds of slowdown in exports caused by regulatory scrutiny and intensifying competition, by monetizing opportunities in ...
Read more: Complex generics, domestic demand to help pharma weather regulated market de-growth: CRISIL

Pharma Reviews: Indian Pharma sector on a positive trajectory, to reach $20 billion mark: ASSOCHAM Study

New Delhi, Dec 27 (KNN) The Indian pharmaceutical exports are likely to touch 30 per cent compound annual growth rate (CAGR) and witness $20 billion in 2020 which is currently $16.5 billion, a study revealed. The study conducted by ASSOCHAM and UL India informed of the possible graph.
Read more: Indian Pharma sector on a positive trajectory, to reach $20 billion mark: ASSOCHAM Study

Pharma Reviews: See Nifty at 12K by Mar 2019; crude hitting $70, return of LTCG in Budget 2018 key concerns ...

If these were to go some sort of into chapter 11, or you could have seen the bottom of pharma companies as far as India is concerned because a lot of market share will be taken by our Indian pharma companies like the Suns and Lupins of the world. And plus, it could also signal some sort of a price ...
Read more: See Nifty at 12K by Mar 2019; crude hitting $70, return of LTCG in Budget 2018 key concerns ...

Pharma Reviews: Govt's medicare drive pinches pharma, pvt hospitals in 2017

By Munish Shekhavat and Ajay Tyagi New Delhi, Dec 27 (PTI) Indian pharmaceutical and healthcare sectors will step into the new year with lingering bitter after-effects of proactive measures of the government, which pulled out all the stops in 2017 for affordable medicare in the country. While the ...
Read more: Govt's medicare drive pinches pharma, pvt hospitals in 2017

Pharma Reviews: Govt's medicare drive pinches pharma, private hospitals in 2017

Indian pharmaceutical and healthcare sectors will step into the new year with lingering bitter after-effects of proactive measures of the government, which pulled out all the stops in 2017 for affordable medicare in the country. While the government's directive to doctors to prescribe only generic names ...
Read more: Govt's medicare drive pinches pharma, private hospitals in 2017

Pharma Reviews: Govt's medicare drive pinches pharma, pvt hospitals in 2017

While the government's directive to doctors to prescribe only generic names unsettled pharma companies, the NPPA's (National Pharmaceutical Pricing ... Summing up 2017, Indian Pharmaceutical Alliance (IPA) Secretary General D G Shah told PTI that the industry was never up against so many ...
Read more: Govt's medicare drive pinches pharma, pvt hospitals in 2017

Pharma Reviews: Pharmexcil gearing up for business tour to African markets from Feb 18-28 to tap unexplored ...

The Pharmaceutical Export Promotion Council of India (Pharmexcil) is planning to venture into African markets to explore export opportunities for Indian pharmaceutical products in the region of DCR Congo, Nigeria and Cote D'lvoir. As part of this, the council is gearing up for a business tour to these ...
Read more: Pharmexcil gearing up for business tour to African markets from Feb 18-28 to tap unexplored ...

US FDA News: Linezolid Injection by Auromedics Pharma: Voluntary Recall - Due to Presence White Particle Matter That Has Been Identified as Mold

AuroMedics Pharma is voluntarily recalling one lot of Linezolid Injection 600mg/300mL flexible bags, NDC 55150 -242 -51 batch CLZ160007 expiration August 2018 to the hospital level. This batch was distributed May 15 through August 14, 2017. The product was found to contain white particulate matter that has been identified as mold.
Read more: Linezolid Injection by Auromedics Pharma: Voluntary Recall - Due to Presence White Particle Matter That Has Been Identified as Mold

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on efforts to support more efficient and effective food recalls

FDA discusses the steps taken to improve the recall process, the HHS OIG report on recalls, and new policies being considered.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on efforts to support more efficient and effective food recalls

Pharma Reviews: Indian pharma industry to touch 20 billion us dollar mark by 2020; heres why its crucial

In a great news for India, while the country is already leading destination for medical tourism across the world, the pharma industry is now slated to touch usd 20 billion mark by 2020 year. This according to the ASSOCHAM study which puts the pharma industry in India currently at 16.5 usd billion worth.
Read more: Indian pharma industry to touch 20 billion us dollar mark by 2020; heres why its crucial

Pharma Reviews: India fast emerging as inventors' hub for drugs patent

Chandigarh, Dec 24 (ANI): India is fast emerging as an inventors' hub for patents for an assortment of drugs worldwide. Around 15 per cent of the total 1.3 lakh patents filed in India from 2013 to 2015 have been contributed by the indigenous pharmaceutical industry. India is ranked second only to the ...
Read more: India fast emerging as inventors' hub for drugs patent

Pharma Reviews: Code for pharma marketing practices may be enforced soon

The law ministry had also sought a clarification on whether the proposed Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) was similar to the professional conduct, etiquette and ethics code of the Indian Medical Council, which doctors must follow in their relationship with pharmaceutical ...
Read more: Code for pharma marketing practices may be enforced soon

Pharma Reviews: Liberate pharmacy education from dual control: Pharmaceutical Congress

Chandigarh [India], Dec.24 (ANI): Arguing that pharmacy education courses are not technical programmes, the 69th Indian Pharmaceutical Congress (IPC) on Sunday passed a resolution that called on the Central Government to liberate all pharmacy courses from dual control of two agencies, the ...
Read more: Liberate pharmacy education from dual control: Pharmaceutical Congress

Pharma Jobs: Medical Coding Jobs For Lifescience/Paramedical Freshers

Company: Achievers Spot
Qualification: BDS, B.E/B.Tech, BAMS, BHMS, B.Pharm, B.Sc, M.E/M.Tech/MS, M.Pharm, Mphil, M.Sc
Experience: 0 to 0
Salary: 1.40 to 3.40
location: Chennai, Madurai
Ref: 21681440
Summary: Medical Coding is the process of conversion of text ....
Read more: Medical Coding Jobs For Lifescience/Paramedical Freshers

Pharma Reviews: A glorious kickstart to 69th Indian Pharma Congress at Chitkara University

Chandigarh , Dec 22 : 69th Indian Pharmaceutical Congress (IPC), a three day International Conference between December 22-24, 2017, kickstarted at Chitkara University, Punjab campus with a grand and glorious inaugural ceremony presided by V. P. Badnore, Hon'ble Governor of Punjab, Brahm ...
Read more: A glorious kickstart to 69th Indian Pharma Congress at Chitkara University

Pharma Reviews: Only pharmacists can stop fake drug menace: Punjab Governor

Chandigarh , Dec.22 : Inaugurating the three-day 69th Indian Pharmaceutical Congress (IPC) at the Chitkara University Campus here on Friday, ... "India is facing huge challenge of fake drug menace, and to minimise it, the pharmacists role is very important apart from regulatory agencies which are ...
Read more: Only pharmacists can stop fake drug menace: Punjab Governor

Pharma Reviews: US FDA Approval for Us Holds Bigger Promise: Kiran Mazumdar-Shaw's Biocon

Biocon's win raises hopes for other Indian pharma companies—some already sell biosimilars in India, including Dr Reddy's Laboratories, Torrent ... Biocon collaborated with Dutch company Mylan NV to develop its biosimilar Trastuzumab, which is sold as Herceptin by the current intellectual property ...
Read more: US FDA Approval for Us Holds Bigger Promise: Kiran Mazumdar-Shaw's Biocon

Pharma Reviews: Epygen Biotech eying Indian biosimilar market with 5 drugs under pipeline

By 2022 global biosimilar market will cross USD 60 billion mark. India has 20 per cent of world's population but it produces just one per cent of world's biologics. By 2022, Indian bio-pharmaceutical space will go up to US$ 5 billion from existing less than US$1 billion. To capitalize on growing biosimilar ...
Read more: Epygen Biotech eying Indian biosimilar market with 5 drugs under pipeline

Pharma Reviews: Hospitals line up higher rate option

Patients' interest groups questioned this logic, asserting that hospitals have no right to profit from the sales of medicines procured at deep discounts from pharmaceutical companies. "Private institutional buyers take maximum advantage of the high MRPs to reap big profits," the All India Drug Action ...
Read more: Hospitals line up higher rate option

US FDA News: FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response

FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response
Read more: FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response

Pharma Reviews: Only pharmacists can stop fake drug menace: Punjab Governor

Inaugurating the three-day 69th Indian Pharmaceutical Congress (IPC) at the Chitkara University Campus here on Friday, Punjab Governor V P Singh Badnore said that pharmacists had a key role to play in stopping the menace of fake drugs entering the market. He called upon pharmaceutical ...
Read more: Only pharmacists can stop fake drug menace: Punjab Governor

Pharma Reviews: A Glorious Kick Start to 69th Indian Pharma Congress at Chitkara University

69th Indian Pharmaceutical Congress (IPC), a three day International Conference between December 22-24, 2017, kick started at Chitkara University, Punjab campus with a grand and glorious inaugural ceremony presided by Sh. V. P. Badnore (Hon'ble Governor of Punjab), Sh. Brahm Mohinder Singh ...
Read more: A Glorious Kick Start to 69th Indian Pharma Congress at Chitkara University

Pharma Reviews: India pharma exports to touch $20 billion by 2020: Study

Indian pharmaceutical exports are likely to touch $20 billion by 2020 from the current level of around $16.5 billion, registering a compounded annual growth rate (CAGR) of about 30 percent, reveals ASSOCHAM and UL India joint study. Indian pharmaceutical sector is expected to register a growth of ...
Read more: India pharma exports to touch $20 billion by 2020: Study

US FDA News: FDA clears stereotactic radiotherapy system for use in treating breast cancer

FDA clears stereotactic radiotherapy system for use in treating breast cancer
Read more: FDA clears stereotactic radiotherapy system for use in treating breast cancer

Pharma Reviews: Indian Pharma Market All Set for a Boom

The Indian pharmaceutical industry is the largest producer of Generics and the market in this segment is expected to see a further boom, along with speciality medicines like Bio-similars owing to many patented products going off patent, says Rahul Darda, Chairman and Managing Director, Brinton ...
Read more: Indian Pharma Market All Set for a Boom

Pharma Reviews: 69th IPCE to flag concerns over import of raw material for drugs

We will be having technical sessions by industry bigwigs during the three-day Congress. In fact, Prof. B Suresh, President, Pharmacy Council of India(PCI) and Dr. G N Singh, Drug Controller General of India, will be attending the inaugural session from 11 a.m. onwards on Dec 22. The theme of the ...
Read more: 69th IPCE to flag concerns over import of raw material for drugs

Pharma Reviews: India pharma exports to touch USD 20 bn by 2020: Study

Indian pharmaceutical exports are likely to touch USD 20 billion by 2020 from the current level of around USD 16.5 billion, registering a compounded ... India is the third-largest global generic Active Pharmaceutical Ingredient (API) manufacturer in terms of market share and generic drugs form the largest ...
Read more: India pharma exports to touch USD 20 bn by 2020: Study

Pharma Reviews: GlobalSpace Technologies launches DocExa to create digital health eco-system

Speaking to Pharmabiz at the launch of the DocExa, Krishna Singh, founder, chairman & managing director, GlobalSpace Technologies said, “DocExa is the industry's first AI driven doctor-pharmaceutical-patient connect platform. Its a step forward towards digital India and by digitally connecting the ...
Read more: GlobalSpace Technologies launches DocExa to create digital health eco-system

Pharma Reviews: India's unpredictable policies affect investments into pharma sector: OPPI

India's unpredictable business environment and lack of infrastructure are the barriers that pharma industry is facing today. The government must lead the way in bringing together world-class infrastructure (research centers) in India to bring newer medicines, treatments and address the unmet medical ...
Read more: India's unpredictable policies affect investments into pharma sector: OPPI

Pharma Reviews: 69th IPCE to flag concerns over import of raw material for drugs

Chandigarh [India], Dec.21 : The 69th Indian Pharmaceutical Congress and Exhibition (IPCE) to be held from December 22-24 here, is expected to focus on flag its concern over India's dependence on import of Active Pharmaceutical Ingredients(API), the crucial raw material for manufacturing drugs.
Read more: 69th IPCE to flag concerns over import of raw material for drugs

US FDA News: FDA approves drug to treat dangerously low blood pressure

The FDA today approved the new drug Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.
Read more: FDA approves drug to treat dangerously low blood pressure

Pharma Reviews: Eased NPPA drug approvals to inject growth into sector

“It is a positive move and will help in ease of doing business,” said Deepnath Roy Chowdhury, president of Indian Drug Manufacturers' Association (IDMA). Cipla declined to comment, while other firms did not respond to queries on the issue. “The NPPA was sitting on applications and was not clearing ...
Read more: Eased NPPA drug approvals to inject growth into sector

Pharma Reviews: Third generation joins DRL

Hyderabad: After being steered by the doyen of the pharma industry, Kallam Anji Reddy, and then jointly driven by his son, Satish Reddy, and son-in-law ... from Hyderabad Public School, Ravi did his BTech from IIT-Bombay in chemical engineering and MBA from premier city-based B-School, the Indian ...
Read more: Third generation joins DRL

Pharma Reviews: Dr Reddy's board gives nod to induct third generation leadership into the company

In pharma sector, finding next level of growth could be challenging task for leadership, believes Tambe. Indian pharmaceutical industry grew at impressive rates in the last two decades on back of generic drugs. However, in last two to three years, companies are increasingly facing pressure on pricing ...
Read more: Dr Reddy's board gives nod to induct third generation leadership into the company

Pharma Reviews: Despite 40% dip in interest in pharma sector jobs, Indian youths throng for Ayurveda jobs in 2017

The number of employees in India seeking to work with the Ayurveda industry has surged significantly when compared to last year, found a leading job search engine Indeed. The spike in interest is attributed to the efforts taken by the government and the home-grown Ayurvedic companies in spreading ...
Read more: Despite 40% dip in interest in pharma sector jobs, Indian youths throng for Ayurveda jobs in 2017

Pharma Reviews: Wockhardt's Habil Khorakiwala Unveils - Odyssey of Courage

The program will entail 12 sessions with Mr. Khorakiwala to help build careers and take businesses to the next level. Commenting on the occasion, Habil Khorakiwala said, "The book chronicles the journey of the Indian Pharma industry, Wockhardt and me. It highlights how important it is to dream big ...
Read more: Wockhardt's Habil Khorakiwala Unveils - Odyssey of Courage

Pharma Reviews: IPCE-17 to focus on Skill development and affordable medicines

Chandigarh, Dec 21 (UNI) Indian Pharmaceutical Congress & Exhibition (IPCE), a National convention of pharmacists, pharma academia, industry and senior Central and State Governments Regulatory officers, will commence at the Chitkara University Campus in Chandigarh, from December 22.
Read more: IPCE-17 to focus on Skill development and affordable medicines

Pharma Reviews: India pharma exports to touch $20 bln by 2020: study

Indian pharmaceutical exports are likely to touch $20 billion by 2020 from the current level of around $16.5 billion, registering a compounded annual growth rate (CAGR) of about 30 per cent, reveals ASSOCHAM and UL India joint study. Indian pharmaceutical sector is expected to register a growth of ...
Read more: India pharma exports to touch $20 bln by 2020: study

Pharma Reviews: 69th IPCE to flag concerns over import of raw material for drugs

The 69th Indian Pharmaceutical Congress and Exhibition (IPCE) to be held from December 22-24 here, is expected to focus on flag its concern over India's dependence on import of Active Pharmaceutical Ingredients(API), the crucial raw material for manufacturing drugs. According to Dr.Shailendra ...
Read more: 69th IPCE to flag concerns over import of raw material for drugs

Pharma Reviews: India developing bulk drugs to reduce import dependence: DCGI

New Delhi, Dec 20 : India is in the process of developing a range of bulk drugs to reduce import dependence, especially from China, a top government official said today. Although a large quantity of bulk drugs is imported from China, India has enough capacity for producing active pharmaceutical ...
Read more: India developing bulk drugs to reduce import dependence: DCGI

US FDA News: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed

FDA review of clinical safety trials shows that treating asthma with LABAs in combination with ICS does not result in significantly more serious asthma-related side effects than treatment with ICS alone.
Read more: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed

Pharma Reviews: National Pharmaceutical Pricing Authority eases norms for new drug approvals

The pharma industry welcomed the step. “These are definitely positive steps taken by the NPPA. These rules were causing a lot of complications, this is therefore a relief to some extent,” said Deepnath Roy Chowdhury, national president, Indian Drugs Manufacturers' Association (IDMA). The launch of ...
Read more: National Pharmaceutical Pricing Authority eases norms for new drug approvals

Pharma Reviews: India may levy anti-dumping duty on Ofloxacin Acid imported from China

NEW DELHI: India is likely to impose antidumping duty of up to USD 8.55 per kg on Chinese imports of a chemical, used mainly by the pharma industry, to protect local manufacturers from below-cost shipments. The Directorate-General of Antidumping and Allied Duties (DGAD) said it has established ...
Read more: India may levy anti-dumping duty on Ofloxacin Acid imported from China

US FDA News: Pantoprazole Sodium for Injection 40 Mg Per Vial: Recall - Presence of Glass Particles

Administration of a glass particulate may result in local irritation or swelling in response to the foreign material. More serious potential outcomes would include blockage and clotting in blood vessels, which may be life-threatening.
Read more: Pantoprazole Sodium for Injection 40 Mg Per Vial: Recall - Presence of Glass Particles

Pharma Reviews: 'Let your work speak for yourself', says Indian management association's Rekha Sethi

The Director General of All India Management Association (AIMA) Rekha Sethi finds a place on the Board of Directors of some leading companies like Sun Pharmaceutical Industries. An student of English from St Stephen's College in Delhi, Rekha started her career with Centre for Development of ...
Read more: 'Let your work speak for yourself', says Indian management association's Rekha Sethi

Pharma Reviews: India may levy antidumping duty on O-acid imported from China

New Delhi, Dec 20 (PTI) India is likely to impose antidumping duty of up to USD 8.55 per kg on Chinese imports of a chemical, used mainly by the pharma industry, to protect local manufacturers from below-cost shipments. The Directorate-General of Antidumping and Allied Duties (DGAD) said it has ...
Read more: India may levy antidumping duty on O-acid imported from China

Pharma Reviews: Wockhardt's Habil Khorakiwala unveils his autobiography 'Odyssey of Courage'

Wockhardt's Habil Khorakiwala has unveiled his autobiography – Odyssey of Courage. The book recounts four different transformation journeys from the time he started his company and survived in the first 10 to 15 years to become an important national pharmaceutical organisation, after liberalisation ...
Read more: Wockhardt's Habil Khorakiwala unveils his autobiography 'Odyssey of Courage'

Pharma Reviews: Wockhardt's Habil Khorakiwala unveils Odyssey of Courage

The programme will entail 12 sessions with Mr Khorakiwala to help build careers and take businesses to the next level. Commenting on the occasion, Mr Khorakiwala said the book chronicles the journey of the Indian Pharma industry, Wockhardt and him. It highlights how important it is to dream big and ...
Read more: Wockhardt's Habil Khorakiwala unveils Odyssey of Courage

Pharma Reviews: Sanofi India elevates N. Rajaram as Managing Director

In a recent announcement, pharma company Sanofi India, has elevated N. Rajaram as managing director. The new role will be effective from January 1, 2018. Rajaram joined the company in January 2014 and was appointed as whole time director in October 2015. Rajaram has nearly two decades of ...
Read more: Sanofi India elevates N. Rajaram as Managing Director

Pharma Reviews: Outlook 2018 : Investments in R & D essential to keep up with market needs

One important market in this regard is India, a very important country for the international health care industry. Indian pharma companies already have the highest number of USFDA approved products but have been mainly focused on generics. In the next year and years, it will become one of the more ...
Read more: Outlook 2018 : Investments in R & D essential to keep up with market needs

US FDA News: Defibrillation Electrodes for Lifepak AEDs by Physio-Control: Class I Recall - Incorrect Placement Instructions for Infants Depicted on Artwork

Incorrect placement of electrodes on an infant may result in failure to deliver an effective shock. A delay in therapy could result in serious injury and/or death.
Read more: Defibrillation Electrodes for Lifepak AEDs by Physio-Control: Class I Recall - Incorrect Placement Instructions for Infants Depicted on Artwork

US FDA News: FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss

FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
Read more: FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss

US FDA News: Gadolinium-based Contrast Agents (GBCAs): Drug Safety Communication - Retained in Body; New Class Warnings

Trace amounts of gadolinium may stay in the body long-term.
Read more: Gadolinium-based Contrast Agents (GBCAs): Drug Safety Communication - Retained in Body; New Class Warnings

Pharma Reviews: Over dependence on drug imports from China harmful for India: IPCA

According to the IPCA, over 75 percent of India's bulk drug imports come from China. That, according to the IPCA, means that India sources around 80 per cent of pharma raw materials to meet growing requirements of drug formulations for Indian pharmaceutical industry. This has emerged as a cause of ...
Read more: Over dependence on drug imports from China harmful for India: IPCA

Pharma Reviews: Lincoln Pharma gets patent for anti-malarial drug

The patent has been awarded by the Indian government for an Arteether injection to treat malaria, according to a BSE filing. The drug is painless and gives faster relief to the patients, Lincoln Pharma said. The company expects significant rise in the revenue from exports to Africa after the introduction of ...
Read more: Lincoln Pharma gets patent for anti-malarial drug

Pharma Reviews: Over dependence on drug imports from China harmful for India: IPCA

New Delhi [India], Dec.19 : An overwhelming dependence on drug imports and related raw materials from China could prove harmful for the health sector in India in the long run, the Indian Pharmaceutical Congress Association (IPCA) has said. According to the IPCA, over 75 percent of India's bulk drug ...
Read more: Over dependence on drug imports from China harmful for India: IPCA

Pharma Reviews: Having run around for parents' medicine, this entrepreneur now makes healthcare a seamless ...

Electronic prescriptions made paper redundant, and Tushar says he was also told which pharmacy would have stock of the medicines he required. ... The Indian pharma industry is currently pegged at $15 billion, and some of the issues that the sector faces include low fill-rates, delivery delays, and ...
Read more: Having run around for parents' medicine, this entrepreneur now makes healthcare a seamless ...

Pharma Reviews: Twin boost for Modi's reforms: What it means for pharma?

After GST rollout, pharma units in Gujarat will have a level-playing field to compete with the states offering tax incentives. We expect more than 50 units to return to Gujarat, and that will improve our share in the India's pharma sector,” said Nirav Mehta, Vice-Chairman, Gujarat State Board of Indian Drug ...
Read more: Twin boost for Modi's reforms: What it means for pharma?

US FDA News: FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs

Today, the U.S. Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would update the FDA’s existing policy to better address situations where homeopathic treatments are being marketed for serious diseases and/or conditions but where the products have not been shown to offer clinical benefits. It also covers situations where products labeled as homeopathic contain potentially harmful ingredients or do not meet current good manufacturing practices.
Read more: FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs

Pharma Reviews: Top stocks in focus on 18 December 2017

Adani Enterprises: India's Adani said on Monday it had canceled plans with Downer EDI Ltd to help develop and run its Carmichael coal mine in Australia after ... DRL, Aurobindo Pharma: Indian drug companies Aurobindo Pharma and Dr Reddy's Laboratories are emerging as the frontrunners to buy out ...
Read more: Top stocks in focus on 18 December 2017

Pharma Reviews: Drug makers can now expect more regular checkups from USFDA

A comparative analysis of FDA inspections in EU, China and India shows higher inspection coverage leads to lower rates of manufacturing violations. During 2010-15, the number of FDA inspections of Indian companies more than doubled to 270 from 108, indicating tighter regulatory oversight. Almost a ...
Read more: Drug makers can now expect more regular checkups from USFDA

Pharma Reviews: Aurobindo, Dr Reddy's Laboratories frontrunners to buy out bankrupt Orchid Pharma

Lakshmi Vilas Bank referred Chennai-based Orchid Pharma to the National Company Law Tribunal for defaulting on repayments to the tune of Rs 50 crore. The company owes more than Rs 3,500 crore to a group of lenders led by the State Bank of India. It was on the Reserve Bank of India's second list ...
Read more: Aurobindo, Dr Reddy's Laboratories frontrunners to buy out bankrupt Orchid Pharma

Pharma Reviews: 'Online pharmacy huge health risk'

New Delhi [India], Dec 17 (ANI): Indian pharmacists fear rise in self-medication and abuse unless online drug sales are checked. In the run up to the 69th Indian Pharmaceutical Congress to be held from December 22-24 in Chandigarh, the hosts of the event Indian Pharmaceutical Congress Association ...
Read more: 'Online pharmacy huge health risk'

Pharma Reviews: Beware price controls on medicines: It will deter pharma industry and choke the supply of quality ...

That in turn will affect the ability and willingness of Indian pharma companies to invest in capacity expansion and research spending which at present is in the range of 8-10% of their sales revenue compared to 20% for multinationals. Obviously, if indigenous pharma companies aren't able to fund the ...
Read more: Beware price controls on medicines: It will deter pharma industry and choke the supply of quality ...

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies

FDA issues two draft guidances that will provide medical product developers with greater clarity on the FDA’s recommendations for researching and developing the next generation of individualized therapies.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies

Pharma Reviews: Volkswagen ups prices up to Rs 20000 from Jan

Amway Queen cookware crosses Rs 100-cr sales Direct selling firm Amway India has said its Amway Queen, the premium cookware range has crossed ... formulations biz to Torrent Pharma firm Unichem Laboratories has completed the sale and transfer of its domestic formulations business in India and ...
Read more: Volkswagen ups prices up to Rs 20000 from Jan

Pharma Reviews: Supreme Court refers fixed dose combination drugs issue to govt expert body

The ban covered about 6,000 brands from major pharma houses including Pfizer Ltd, Wockhardt Ltd, Alkem Laboratories Ltd, Cipla Ltd, Sanofi India Ltd, and Sun Pharmaceutical Industries Ltd. It was enforced following a report by a six-member committee headed by Chandrakant Kokate, vice-chancellor ...
Read more: Supreme Court refers fixed dose combination drugs issue to govt expert body

Pharma Reviews: Volkswagen ups prices up to Rs 20000 from Jan

Unichem sells domestic formulations biz to Torrent Pharma firm Unichem Laboratories has completed the sale and transfer of its domestic formulations business in India and Nepal, by way of a slump sale to Torrent Pharma. Last month, Torrent announced that it would acquire branded business of ...
Read more: Volkswagen ups prices up to Rs 20000 from Jan

US FDA News: Blue Pearl All Natural Male Enhancement Supplement: Recall - Undeclared Drug Ingredient

Undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.
Read more: Blue Pearl All Natural Male Enhancement Supplement: Recall - Undeclared Drug Ingredient

Pharma Reviews: Torrent Pharma completes acquisition of Unichem Laboratories Ltd

The acquisition will accelerate Torrent's presence in the chronic space especially in the high growth segments of Indian Pharma market like Cardiology, Diabetology and Gastroenterology. Moreover, Unichem brings in an important new platform in Torrent's sustainable growth strategy by expanding the ...
Read more: Torrent Pharma completes acquisition of Unichem Laboratories Ltd

Pharma Reviews: How US Tax Reforms May Impact India Inc.

So which Indian sectors are likely to get impacted the most? IT-ITES, pharmaceuticals and contract manufacturing are the sectors that would definitely be affected said Maulik Doshi, partner at SKP Business Consulting. Rupak Saha, tax partner at PWC India was more circumspect about the impact of the ...
Read more: How US Tax Reforms May Impact India Inc.

Pharma Reviews: CPhI-P-MEC India Expo 2017 Catapults the Pharma Sector to New Heights

UBM India, India's leading B2B exhibition organizer, enthralled the pharma industry and brought it to a standstill with the grand 11th edition of its signature event, CPhI & P-MEC India 2017, that was held at two venues in Mumbai - MMRDA Grounds, Bandra-Kurla Complex (27^th to 29^th November) and ...
Read more: CPhI-P-MEC India Expo 2017 Catapults the Pharma Sector to New Heights

Pharma Reviews: Kochi fast emerging as petrochemical hub

KOCHI: Kochi is set to become a major hub for the petrochemical industry in India with the BPCL Kochi Refinery, Kerala State Industrial Development Corporation (KSIDC) and Kerala Industrial Infrastructure ... An area of 30-40 acres in the park will be earmarked for pharma companies'' he added.
Read more: Kochi fast emerging as petrochemical hub

US FDA News: FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care

Today the FDA is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance. The agency created a website that will provide direct and timely access to information about when bacterial or fungal infections are likely to respond to a specific drug.
Read more: FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care

Pharma Reviews: The US Squeeze

The way India's largest drug maker Sun Pharmaceutical rose and fell in the US, a country that accounts for 44 per cent of the $1.1 trillion global drug market, is an indication of the challenges that the Indian pharmaceutical industry is facing in that market. Sun entered the US in 2008/09 by acquiring ...
Read more: The US Squeeze

Pharma Reviews: Growing Worries

The India pharmaceutical industry is incredible in more ways than one. On the one hand, it takes pride in the fact that India is home to the largest number of drug-making facilities outside the US that are approved by the US Food and Drug Administration (USFDA) - over 600 of them. And in the fact that ...
Read more: Growing Worries

Pharma Reviews: Women Achievers- KANCHANA TK

Being one among the very few women who make it to senior roles in industry, Kanchana TK, Director General, Organisation of Pharmaceutical Producers of India (OPPI) has not hesitated to make bold career moves. Her professional experience of over two decades at the leading edge of a spectrum of ...
Read more: Women Achievers- KANCHANA TK

Pharma Reviews: No Easy Cure

The pharmaceutical industry in India is in serious need of a strategy rethink. Constant policy interventions for over a year and the growing uncertainties around those have sorely hit the sector, so much so that the key players are determined to get better of those deterrents and regain their growth ...
Read more: No Easy Cure

Pharma Reviews: Drug Wars

It was a tough call as import of these low-cost key active pharmaceutical ingredients (APIs), or raw materials - almost entirely from China - was helping Indian formulation companies, or entities that make syrups, tablets, injections, etc, remain competitive. An increase in medicine prices due to rise in input ...
Read more: Drug Wars

US FDA News: FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome

FDA approves first drug for a rare autoimmune disease that causes an inflammation in the wall of blood vessels of the body. This is a new indication for a previously-approved drug.
Read more: FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome

US FDA News: FDA warns companies for promoting alternatives to street drugs

The FDA today posted a warning letter to the marketers and distributors of Legal Lean Syrup, a drink, and Coco Loko, a “snortable” chocolate powder, for selling unapproved new drugs and misbranded drugs.
Read more: FDA warns companies for promoting alternatives to street drugs

Pharma Reviews: Antibiotics & asthma drugs help Indian pharma market to grow at 8.1% in Nov

The Indian pharmaceutical market (IPM) grew 8.1 percent in November, the highest growth for any month so far in FY18, helped by improved uptake in anti-infectives, respiratory and gastrointestinal segments, despite gradual recovery from the disruption caused by GST transition, according to market ...
Read more: Antibiotics & asthma drugs help Indian pharma market to grow at 8.1% in Nov

Pharma Reviews: 'India Inc's November M&A deal tally grows 55% to $3 bn'

NEW DELHI: India Inc's merger and acquisition activity registered a growth of 55 per cent year- on-year in November with deals worth USD 3.2 billion, ... November also witnessed Torrent Pharma's biggest acquisition till date with Unichem Laboratories' Indian and Nepal businesses for USD 554 million.
Read more: 'India Inc's November M&A deal tally grows 55% to $3 bn'

Product Recall Alerts: Inmar Acquires RASMAS from Noblis

Inmar, a leading provider of recall and product withdrawal services for both pharmaceutical and consumer goods in the U.S. and Canada, has served as the exclusive reseller of RASMAS on behalf of Noblis, Inc. for the past eight years. RASMAS helps its pharmacy clients reduce alert processing time by ...
Read more: Inmar Acquires RASMAS from Noblis

US FDA News: FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes

The FDA today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus. Admelog is the first short-acting insulin approved as a “follow-on” product.
Read more: FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes

US FDA News: FDA launches public education campaign to encourage adult smokers trying to quit cigarettes

Today, the U.S. Food and Drug Administration announced an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit through messages of support that underscore the health benefits of quitting. These messages will be displayed in and around gas stations and convenience stores – retail locations where smokers face a multitude of triggers and that typically feature cigarette advertisements. The “Every Try Counts” campaign targets smokers ages 25-54 who have attempted to quit smoking in the last year but were unsuccessful. The two-year campaign launches next month in 35 U.S. markets and features print, digital, radio, and out-of-home ads, such as on billboards.
Read more: FDA launches public education campaign to encourage adult smokers trying to quit cigarettes

Pharma Reviews: Schott Kaisha introduces path breaking innovation in pharma packaging

Schott Kaisha has introduced state-of-the art technologies and path-breaking innovations in the pharmaceutical primary packaging space. With its advanced operational capabilities, Schott Kaisha was the first manufacturer of glass syringes and cartridges in India, and continues to be a prime supplier for ...
Read more: Schott Kaisha introduces path breaking innovation in pharma packaging

Pharma Reviews: Indian pharma market improves by 8.1% to Rs.10291 crore in Nov'17

Indian Pharmaceutical Market (IPM) improved during the month of November 2017 due to positive growth in volumes. According to AIOCD Pharmasofttech AWACS Pvt. Ltd, IPM has clocked growth of 8.1 per cent to Rs.10,291 crore. However, due to GST implementation, the growth in April-November for ...
Read more: Indian pharma market improves by 8.1% to Rs.10291 crore in Nov'17

Pharma Reviews: Closing bell: Sensex gains 205 pts, Nifty closes above 10300; paper stocks rally

2:50 pm Market Outlook: BNP Paribas maintains its overweight stance on Indian markets and sees the S&P BSE Sensex heading towards 37,500, .... 12:40 pm USFDA Inspection: Pharma firm Granules India today said its US subsidiary has received an observation from the USFDA on completion of ...
Read more: Closing bell: Sensex gains 205 pts, Nifty closes above 10300; paper stocks rally

Pharma Reviews: Investors Prefer Mid Caps Over Large Caps In Indian Pharma Sector, Macquarie Says

Brokerage house Macquarie said Asian investors prefer mid-cap pharma companies over their larger counterparts where they remain cautious. Most investors are wary of investing in the U.S. centric large-cap stocks after the massive stock price correction over the last one-and-a-half to two years, the ...
Read more: Investors Prefer Mid Caps Over Large Caps In Indian Pharma Sector, Macquarie Says

Pharma Reviews: Pharma sector bats for higher standards

The captains of the Indian pharmaceutical industry have stressed on the need to achieve high quality standards to enable India partake a large part of the global pharmaceutical market. The emphasis comes in the wake of multiple negative actions taken by the USFDA against products and facilities of ...
Read more: Pharma sector bats for higher standards

Pharma Reviews: TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastest: Wealth Creation Study

Anuj: It is interesting we have been talking about a bear market for pharmaceutical but for last three years it is a pharmaceutical company which have been the fastest wealth creator, Ajanta Pharma. In the past also we have seen couple of pharmaceutical companies do that. So do you think Indian ...
Read more: TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastest: Wealth Creation Study

Pharma Reviews: Is Indian Bioeconomy outgrown the Pharma industry?

ABLE, a biotech industry lobby group formed in 2003, in its report noted that the Indian bioeconomy has crossed $42 billion in 2017 and biotechnology industry is valued at $19 billion. Contrary to this, India Brand Equity Foundation (IBEF), in its Biotechnology Sector Report - March 2017 referring to ...
Read more: Is Indian Bioeconomy outgrown the Pharma industry?

US FDA News: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. Senate Committee on Health, Education, Labor & Pensions Hearing, “Implementation of the 21st Century Cures Act: Progress and the Path Forward for Medical Innovation

FDA Commissioner Gottlieb testifies before the U.S. Senate Committee on Health, Education, Labor & Pensions on the agency’s implementation of the 21st Century Cures Act
Read more: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. Senate Committee on Health, Education, Labor & Pensions Hearing, “Implementation of the 21st Century Cures Act: Progress and the Path Forward for Medical Innovation

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation

Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation

Pharma Reviews: Agri Buzz: SEA of India Estimates 93 percent Rise In Oilmeal Exports During November 2017

As per the latest release by Solvent Extractors Association of India (SEA OF India), the export during November 2017 is provisionally reported at 328,091 tons ... This steps will make Indian oilmeal more competitive in the world market and may result in to larger export of oilmeals during current year.
Read more: Agri Buzz: SEA of India Estimates 93 percent Rise In Oilmeal Exports During November 2017

Pharma Reviews: Precision medicine: Zuckerberg backs Indian-origin scientist with formula to jolt drug market

What Butte aims to do in simple terms is drug re-positioning - can an old medicine treat a new or another disease? It is not about getting a new drug out in the market, but finding a new use for an old drug that we already have. This is significant because big pharma spends billions of dollars and decades ...
Read more: Precision medicine: Zuckerberg backs Indian-origin scientist with formula to jolt drug market

Pharma Reviews: Economic Buzz: Australia Construction Activity Climbs To 4-Month High In November

By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in ...
Read more: Economic Buzz: Australia Construction Activity Climbs To 4-Month High In November

Pharma Reviews: IVCA, Quadria Capital to host India Healthcare Leadership Summit 2017 on December 7 at Taj ...

IVCA, Quadria Capital to host India Healthcare Leadership Summit 2017 on December 7 at Taj Lands End Hotel, Mumbai ... Industry experts, professionals and leaders from country's leading private equity fund houses, healthcare companies, hospitals, pharma companies, consulting ventures and tax ...
Read more: IVCA, Quadria Capital to host India Healthcare Leadership Summit 2017 on December 7 at Taj ...

Pharma Reviews: IVCA & Quadria Capital to Host India Healthcare Leadership Summit 2017

At IVCA, we are setting up a platform for the overall healthcare industry to get together and discuss aspects from around regulatory landscape, generics, biosimilars, investor perspective on healthcare delivery and healthcare startups. With this, we aim output driven discussions on relevant and burning ...
Read more: IVCA & Quadria Capital to Host India Healthcare Leadership Summit 2017

Pharma Reviews: This Indian company is ready to flood the US with cheap HIV drugs

In the U.S., Laurus will be going up against much larger companies like Teva Pharmaceutical Industries Ltd. — the world's biggest generic drug company — which will beat it to market on generic Viread and so be the first to slash prices and lock down customers. Other generic companies, both from India ...
Read more: This Indian company is ready to flood the US with cheap HIV drugs

Pharma Reviews: This company is ready to flood the US with cheap HIV drugs

For generic manufacturers like Laurus, the U.S. market is alluring. ... he left his job as a C-suite executive at another Indian pharma company to found ...
Read more: This company is ready to flood the US with cheap HIV drugs

Pharma Reviews: Indiabulls Pharma raises ₹155 cr from Clermont Group

Indiabulls Pharmaceuticals, an Indiabulls Group company, has raised ₹155 crore from Singapore-based investment firm Clermont Group. The company will use the investments to strengthen its healthcare products and services in India, with the intention of being amongst the top 10 players in the coming ...
Read more: Indiabulls Pharma raises ₹155 cr from Clermont Group

US FDA News: Pharmacist Choice Alcohol Prep Pads by Simple Diagnostics: Recall - Lack of Sterility Assurance and Other Quality Issues

The use of impacted alcohol prep pads could result in adverse events such as infections.
Read more: Pharmacist Choice Alcohol Prep Pads by Simple Diagnostics: Recall - Lack of Sterility Assurance and Other Quality Issues

Pharma Reviews: NZ billionaire backs Indiabulls Pharma

The company "is aiming to reshape the Indian pharmaceutical industry landscape by providing next-generation therapies to patients at affordable ...
Read more: NZ billionaire backs Indiabulls Pharma

Pharma Reviews: Indiabulls Pharma receives Rs 155 crore investment from Clermont Group

“At Indiabulls Pharmaceuticals, we want to reshape the Indian pharmaceutical industry landscape by providing next generation therapies to patients at affordable prices. We aspire to be a patient and physician centric, innovative, best-in-class pharmaceutical company,” said Mr. Nikhil Chari, CEO of ...
Read more: Indiabulls Pharma receives Rs 155 crore investment from Clermont Group

Pharma Reviews: Laurus Labs is ready to flood the US with cheap HIV drugs

In the US, Laurus will be going up against much larger companies like Teva Pharmaceutical Industries Ltd — the world's biggest generic drug company — which will beat it to market on generic Viread and so be the first to slash prices and lock down customers. Other generic companies, both from India ...
Read more: Laurus Labs is ready to flood the US with cheap HIV drugs

Pharma Reviews: Abuse of drugs

Almost 50 per cent of India's Rs 2.20-lakh-crore annual revenue of the pharmaceutical industry comes from exports. They are under constant regulatory control in the US and Europe on quality, production procedure, packaging and price. The producers can't grumble. Either they fall in line or they lose ...
Read more: Abuse of drugs

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA ushering in new era of 3D printing of medical products; provides guidance to manufacturers of medical devices

The FDA is issuing final guidance on the technical considerations for the 3D printing of medical devices. The recommendations clarify what the FDA recommends manufacturers include in submissions for 3D printed medical products.
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA ushering in new era of 3D printing of medical products; provides guidance to manufacturers of medical devices

Pharma Reviews: This Company Is Ready to Flood the US With Cheap HIV Drugs

In the U.S., Laurus will be going up against much larger companies like Teva Pharmaceutical Industries Ltd. -- the world's biggest generic drug company -- which will beat it to market on generic Viread and so be the first to slash prices and lock down customers. Other generic companies, both from India ...
Read more: This Company Is Ready to Flood the US With Cheap HIV Drugs

Pharma Reviews: AVPS Chakravarthi honoured at India Pharma awards

Chakravarthi said, “The very recognition of a packaging technologist at India Pharma Awards reiterates the growing importance of packaging in the pharmaceutical sector. Pharma packaging is close to my heart and though it lacks glamour it has all other ingredients and host of challenges as well.”.
Read more: AVPS Chakravarthi honoured at India Pharma awards

Pharma Reviews: Growth policies being drawn up for each sector: Prabhu

Commerce Minister Suresh Prabhu Friday said that the government is working towards drawing up policies for various sectors of the Indian economy ... on the pharma sector, Prabhu said the latter had spoken of $100 billion worth of business being achievable by the Indian pharma and biotech industry.
Read more: Growth policies being drawn up for each sector: Prabhu

Pharma Reviews: Urging support, Pharma Sector to present white paper before the government

New Delhi, Dec 2 (KNN) Pharma industry leaders and stakeholders participated in a discussion on Indian Pharmaceutical Industry in a CEO Round Table as part of the 2nd edition of India Pharma Week, a UBM India initiative introduced to celebrate a decade of CPhI & P-MEC. The industry would soon ...
Read more: Urging support, Pharma Sector to present white paper before the government

Pharma Reviews: India's top 20% pharmaceutical workforce is on par with global standards: Uma Nandan Misra

The move to be aggressive in training candidates also ensues from the Drugs Control General of India's notification which has targeted that by 2018, pharma sector personnel will need focused training across specializations. In order to play a critical role generating the trained workforce, Pharma ...
Read more: India's top 20% pharmaceutical workforce is on par with global standards: Uma Nandan Misra

Pharma Reviews: Nifty, Sensex May Remain Weak – Weekly closing report

The key Indian equity indices on Monday were trading lower on Monday, in line with the closing values of Asian indices. ... Shares of Sun Pharmaceutical Industries slipped nearly 2% in early trade on Monday after the pharma company on Friday announced that its US-based subsidiary is recalling two ...
Read more: Nifty, Sensex May Remain Weak – Weekly closing report

US FDA News: FDA approves first biosimilar for the treatment of certain breast and stomach cancers

FDA approves first biosimilar for the treatment of certain breast and stomach cancers
Read more: FDA approves first biosimilar for the treatment of certain breast and stomach cancers

Pharma Reviews: DRL's subsidiary receives FDA nod for anti-psoriasis cream

A statement from the drug maker said it is a first-cycle NDA (new drug application) approval for the Proprietary Products Group, a substantial milestone within the pharmaceutical industry. Impoyz (clobetasol propionate) cream, 0.025 per cent, is a high-potency topical steroid approved for the treatment of ...
Read more: DRL's subsidiary receives FDA nod for anti-psoriasis cream

US FDA News: Albumin Human 25 Percent Solution (AlbuRx 25): Product Information Advisory - Fading Print On Label

Potential for fading print, with more effect on the expiration dating on the patient tear off portion of the vial label.
Read more: Albumin Human 25 Percent Solution (AlbuRx 25): Product Information Advisory - Fading Print On Label

US FDA News: Bull Capsules, Chao Jimengnan Tablets by Nutra Labs: Recall - Undeclared Drug Ingredients

Undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening.
Read more: Bull Capsules, Chao Jimengnan Tablets by Nutra Labs: Recall - Undeclared Drug Ingredients

Pharma Reviews: Growth policies being drawn up for each sector: Prabhu

Informing the audience that he had met with IT industry body Nasscom and Biocon Chairperson Kiran Mazumdar Shaw on the pharma sector, Prabhu said the latter had spoken of $100 billion worth of business being achievable by the Indian pharma and biotech industry. "At the Gold Council event today ...
Read more: Growth policies being drawn up for each sector: Prabhu

Pharma Reviews: Pharmexcil to conduct interactive meeting with Cuban delegation on Dec 7 in New Delhi

The Pharmaceutical Export Promotion Council of India (Pharmexcil) is planning to conduct an interactive meeting with a high level delegation from Cuba on December 7 in New Delhi. As part of this the council is seeking participation from senior officials from the industry, government and policy makers ...
Read more: Pharmexcil to conduct interactive meeting with Cuban delegation on Dec 7 in New Delhi